CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma - Wikidata - awgldk - TriplyDB

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

http://www.wikidata.org/entity/Q36657755

about

Pregnane X Receptor and Cancer: Context-Specificity is Key.Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine.Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.Molecular subtypes in cancers of the gastrointestinal tract.Functions of pregnane X receptor in self-detoxification.Perspective of αvβ6-Integrin Imaging for Clinical Management of Pancreatic Carcinoma and Its Precursor Lesions.Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.Survival of pancreatic cancer cells lacking KRAS function.Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology.Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.Barcelona conference on epigenetics and cancer 2016 - beyond cancer genomes.Defining the molecular pathology of pancreatic body and tail adenocarcinoma.Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.Preclinical mouse solid tumour models: status quo, challenges and perspectives.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.Single cell polarity in liquid phase facilitates tumour metastasis.Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance Pancreatic cancer subtypes: a roadmap for precision medicine Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β

P2860

Q37243869-F7094CFC-BF43-4075-BA86-7C9576F01EE9 Q37726365-B2EC4214-3056-4233-B8DB-3164F77FE126 Q37733990-E0AF8A26-1589-4757-B6A0-6330D9B1D5C1 Q38851906-E479D2B9-ECF8-41A6-9141-C9C5049F9258 Q38854079-45210776-B8AC-433F-9CC6-AAFD1ED5059E Q38937177-C1C6A65E-EF14-410A-BB37-BC626CE9F645 Q39028343-C58AF52A-CAC4-41D0-B055-BC940CFCFA5E Q39235977-E0EB338A-F28D-4517-8D3D-4D819059F657 Q39324093-3B6751D7-58F3-42C5-9EBB-9441BD55CE05 Q41068463-C4CEA420-F058-4CD4-B055-ED063840FD6E Q41621110-EF145CE3-0484-4D85-ACBF-6046547F7599 Q42645888-0A80125A-EE64-479B-B79F-CEF06C63EAAE Q42700517-1F68790F-85D9-4508-8B95-C51B30DF2DAE Q47096668-F6FEA6EF-A45F-481F-B746-780444EA0C30 Q47143099-59B6F4FB-C852-46CC-B3B8-01E8A74287BF Q47577915-CF725221-8E19-4FCF-AA51-919102AF73D9 Q48229462-72C11DF8-262B-4CC0-9B1B-DE82CB1D1999 Q48838047-462A9FC2-81FA-4DBE-AB40-0A69E05FB924 Q49547506-1ECD6A1C-3CC3-4CD7-AAE6-95C85BD2015B Q50096902-0F124921-FB27-4C6F-AFD5-0FA213574C39 Q50179674-F2D30BF2-0816-4690-AB10-E05593FB505F Q50868185-5ADE1E7A-BB9C-42A3-BA48-10089326C36C Q54277914-253634A1-C8FB-4720-A387-5C8155A2AAC3 Q56530315-2E1695B7-0415-49B4-AFAF-6668351C4D00 Q56761472-81BF5F3C-2E5F-4AC3-9813-06B67C96BB85 Q58146806-10ECC7FD-C550-4E32-B2B0-5442006F5A4D Q58777450-662F0B3F-5B59-43A4-B02B-3B8D4376F6F0

P2860

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

http://www.wikidata.org/entity/Q36657755

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@ast

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@en

type

label

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@ast

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@en

prefLabel

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@ast

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@en

P1433

Q36657755-9283F16E-E34C-4311-84DA-438A1FEBA817

P1476

Q36657755-CF875271-7A03-46FE-A7AD-AA820B56206A

P2093

Q36657755-0A686C30-E9DC-4DF9-B1C6-53B8535057E8

Q36657755-0DB28363-B350-4824-A3A5-DEE1C87BE28A

Q36657755-1799F310-D0B1-4A81-BA8C-91E82353564C

Q36657755-1DD2CAF3-90F0-4E08-BCA4-C01395731C24

Q36657755-28C38467-5FD0-41CF-B498-DFE67E3F935C

Q36657755-2FE00D67-E9AB-4D05-89D3-6DE5E72EC15D

Q36657755-325A50A3-1E19-4CAB-BEED-85B1F9D9DAB2

Q36657755-39C912D3-AC2D-4E75-ABCB-E114C1B2E161

Q36657755-57461FC1-BC3B-4070-A1F8-EEA654EC5D17

Q36657755-6E5B388C-242F-4DE8-8391-A5E47270A653

P2860

Q36657755-0A4338DE-30D4-48D7-B7D4-0828AA7E5042

Q36657755-101B4BD3-8E60-4E75-873B-AEAE25114F35

Q36657755-1090D3E4-71D4-4E19-A94D-548B909AAC56

Q36657755-16FB70E8-4772-48F7-8FBD-7C9D14EB42F7

Q36657755-184808BF-FFC8-4F23-A3FC-7784B2A69410

Q36657755-195F71AD-EC74-49B9-A320-CED98B8A30D9

Q36657755-1C625A4D-61A2-4592-B1FB-CEA42A3FB58E

Q36657755-1F080F0C-6A38-4D23-AEEC-2E21D05FC145

Q36657755-1F80E72B-2C5F-48EA-8895-A97D9A0DE788

Q36657755-2592ECF3-78C0-4F21-9BAE-8146D2AA2F18

P2888

Q36657755-4A233785-3F7E-4119-8D4E-BE3FE3E1323E

P304

Q36657755-3C08ECB5-85E7-40F5-8CA6-48EDFCB69DD0

P31

Q36657755-932C4623-866B-40AF-B4A0-4C6282B5DA04

P356

Q36657755-5E256D40-065A-44B2-A261-4EFADE057418

P407

Q36657755-60A19E9F-5CC8-4B49-90C4-F53B0120D7C2

P433

Q36657755-23402FB7-2683-471A-9A32-BF9F5EAEEB84

P478

Q36657755-B477996A-AB3F-48D9-9199-1D23DF23D46E

P50

Q36657755-146F9AC1-75F1-4B67-952F-3D3650DB7A83

Q36657755-432D249C-E3B8-4C89-9555-ADD26E4A21B3

Q36657755-79B99E84-1F3D-475E-9E14-EEE455AE35E9

Q36657755-8B704287-0BD2-49E8-9F16-9A9A392148A5

Q36657755-95609493-08A0-4843-A46B-28C4D3C2D90D

Q36657755-A9050257-AB7F-47DC-818E-9C4A3F45D113

Q36657755-B0DBD7C3-B3BA-494C-A904-A02BB849D9B2

Q36657755-E47B89A3-C025-46E4-A310-35F0DE8EDE4C

P577

Q36657755-92FB33DB-E409-4050-A6C3-0770DE9D039E

P6179

Q36657755-4372E32A-DFB3-4DFE-89D8-66CEBF4C5705

P698

Q36657755-1198B684-C367-49ED-8623-DD45E24EFBBE

P932

Q36657755-274EE33E-1472-48EC-9B87-7A39837C6BF0

P356

P1433

Nature Medicine

P1476

CYP3A5 mediates basal and acqu ...... ncreatic ductal adenocarcinoma

@en

P2093

Albrecht Stenzinger

http://www.w3.org/2001/XMLSchema#string

Alexander Muckenhuber

http://www.w3.org/2001/XMLSchema#string

Annette Kopp-Schneider

http://www.w3.org/2001/XMLSchema#string

Bernd Klaus

http://www.w3.org/2001/XMLSchema#string

Bruno V Sinn

http://www.w3.org/2001/XMLSchema#string

Christian Eisen

http://www.w3.org/2001/XMLSchema#string

Christian Lutz

http://www.w3.org/2001/XMLSchema#string

Christoph Rösli

http://www.w3.org/2001/XMLSchema#string

Corinna Klein

http://www.w3.org/2001/XMLSchema#string

Elisa Espinet

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of an endogenous ligand bound to a native orphan nuclear receptor

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Significance analysis of microarrays applied to the ionizing radiation response

Recent progress in pancreatic cancer

Evolution and dynamics of pancreatic cancer progression

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma

Cancer statistics, 2015

The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4

P2888

P304

278-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.4038

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Martin R. Sprick

Markus Büchler

P577

2016-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018951632

http://www.w3.org/2001/XMLSchema#string

P698

26855150

http://www.w3.org/2001/XMLSchema#string

P932

4780258

http://www.w3.org/2001/XMLSchema#string